{
    "clinical_study": {
        "@rank": "158107", 
        "acronym": "Salmon-Basel", 
        "arm_group": [
            {
                "arm_group_label": "Salbutamol", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Sugar Syrup", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Aim is to investigate the effect of beta2 adrenergic stimulant salbutamol on emotional and\n      cognitive functions in healthy humans."
        }, 
        "brief_title": "Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Memory Functions", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy, male and female, aged between 18 and 40, BMI be-tween 19 and 27 kg/m2,\n        normotensive (BP between 90/60 mmHg and 140/90 mmHg), native or fluent German-speaking,\n        caucasian (European ancestry), able and willing to give written informed consent and\n        comply with the requirements of the study protocol, willing to donate saliva sample for\n        DNA-analysis -\n\n        Exclusion Criteria:\n\n        Acute or chronic psychiatric or somatic disorder, tachycardia at rest (> 100 bpm), known\n        hypersensitivity to salbutamol, pathological ECG, pregnancy, breast-feeding, long-term\n        medication within last 3 months (oral contraceptives are disregarded) smoking (>3\n        cigarettes per day), concurrent participation in another study, participation in one of\n        our previous studies using the same memory tests, inability to read and understand the\n        participant's information. -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957293", 
            "org_study_id": "2013DR2134"
        }, 
        "intervention": [
            {
                "arm_group_label": "Salbutamol", 
                "description": "single oral administration, 4 mg", 
                "intervention_name": "Salbutamol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sugar Syrup", 
                "description": "single oral administration", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Albuterol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Basel", 
                    "country": "Switzerland", 
                    "zip": "4055"
                }, 
                "name": "University of Basel, Division of Cognitive neuroscience"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects", 
        "overall_official": {
            "affiliation": "University of Basel", 
            "last_name": "Dominique de Quervain, Prof. MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "memory tests", 
                "measure": "Change of emotional memory functions under Salbutamol", 
                "safety_issue": "No", 
                "time_frame": "two testing days within 10 days"
            }, 
            {
                "description": "memory tests", 
                "measure": "Change of episodic memory functions under Salbutamol", 
                "safety_issue": "No", 
                "time_frame": "two testing days within10 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957293"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Basel", 
            "investigator_full_name": "Prof. Dominique de Quervain, MD", 
            "investigator_title": "Director of teh Division of Cognitive Neuroscience", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "questionnaires", 
                "measure": "Change of emotional state under salbutamol", 
                "safety_issue": "No", 
                "time_frame": "Two testing days within 10 days"
            }, 
            {
                "description": "attention tests", 
                "measure": "change of attention functions under salbutamol", 
                "safety_issue": "No", 
                "time_frame": "two testing days within 10 days"
            }
        ], 
        "source": "University of Basel", 
        "sponsors": {
            "collaborator": {
                "agency": "Clinical Trial Unit, University Hospital Basel, Switzerland", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Prof. Dominique de Quervain, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}